Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Mesenteric lymph node immune function refers to the collective immunological activities occurring within the lymph nodes located in the mesentery, which drain the small and large intestines (Mowat, A. M., Nature Reviews Immunology, 2003). These nodes serve as critical hubs for the induction of mucosal immune responses and the maintenance of oral tolerance, filtering antigens derived from the gut lumen and coordinating the activation and trafficking of T and B lymphocytes (Girard, J. P., et al., Nature Reviews Immunology, 2012). In pathological states such as inflammatory bowel disease (IBD), the mesenteric lymph nodes become sites of chronic inflammation and aberrant immune cell priming (Danese, S., et al., Gut, 2015). While not a single molecular target, this system is the site of action for several therapeutic classes, including sphingosine-1-phosphate (S1P) receptor modulators like ozanimod that sequester lymphocytes within the nodes and integrin inhibitors like vedolizumab that disrupt the migration of activated cells from the nodes to the intestinal mucosa (Sandborn, W. J., et al., New England Journal of Medicine, 2013). Furthermore, the MLNs play a role in the systemic spread of intestinal infections and the pathogenesis of mesenteric adenitis (Helbling, R., et al., Journal of Pediatric Surgery, 2012). Understanding MLN function is essential for developing therapies that can selectively modulate gut-specific immunity without inducing systemic immunosuppression.
Modulation of lymphocyte egress via sphingosine-1-phosphate (S1P) receptors, inhibition of leukocyte trafficking via integrin antagonism, and neutralization of pro-inflammatory cytokines.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Mesenteric lymph node immune function (MLN immune function).